A Study to Evaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes Patients

NCT01845064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: DM199
DRUG: Placebo

Sponsor

DiaMedica Therapeutics Inc